Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$9.53B |
| 2 |
Gilead Sciences
GILD
|
+$8.17B |
| 3 |
Microsoft
MSFT
|
+$7.02B |
| 4 |
Amgen
AMGN
|
+$6.96B |
| 5 |
Altria Group
MO
|
+$5.42B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.95% |
| 2 | Technology | 12.52% |
| 3 | Communication Services | 11.55% |
| 4 | Industrials | 10.7% |
| 5 | Consumer Staples | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Citigroup
C
$231B
| $441M | 0.19% |
+9,201,000
| New | +$442M |
|
|
LLTC
127
DELISTED
Linear Technology Corp
LLTC
| $427M | 0.18% |
+11,587,216
| New | +$426M |
|
128
Halliburton
HAL
$27.7B
| $411M | 0.17% |
+9,850,000
| New | +$412M |
|
129
Wynn Resorts
WYNN
$10.6B
| $410M | 0.17% |
+3,200,000
| New | +$426M |
|
130
International Flavors & Fragrances
IFF
$21.4B
| $405M | 0.17% |
+5,384,500
| New | +$420M |
|
131
Harley-Davidson
HOG
$2.7B
| $397M | 0.17% |
+7,249,841
| New | +$392M |
|
|
NYX
132
DELISTED
NYSE EURONEXT INC
NYX
| $387M | 0.16% |
+9,338,640
| New | +$370M |
|
|
EMC
133
DELISTED
EMC CORPORATION
EMC
| $386M | 0.16% |
+16,360,000
| New | +$386M |
|
134
Public Storage
PSA
$60.4B
| $380M | 0.16% |
+2,477,200
| New | +$390M |
|
135
Williams-Sonoma
WSM
$28.9B
| $376M | 0.16% |
+13,440,866
| New | +$362M |
|
136
Petrobras Class A
PBR.A
$103B
| $372M | 0.16% |
+25,372,000
| New | +$462M |
|
|
GRMN
137
Garmin
GRMN
$59.8B
| $364M | 0.15% |
+10,073,672
| New | +$350M |
|
138
Abbott
ABT
$192B
| $363M | 0.15% |
+10,405,000
| New | +$382M |
|
139
lululemon athletica
LULU
$13.7B
| $360M | 0.15% |
+5,494,100
| New | +$398M |
|
140
Bristol-Myers Squibb
BMY
$130B
| $359M | 0.15% |
+8,025,000
| New | +$348M |
|
|
ESRX
141
DELISTED
Express Scripts Holding Company
ESRX
| $358M | 0.15% |
+5,807,000
| New | +$350M |
|
142
Analog Devices
ADI
$187B
| $355M | 0.15% |
+7,880,627
| New | +$355M |
|
|
ENDP
143
DELISTED
Endo International plc
ENDP
| $349M | 0.15% |
+9,491,400
| New | +$341M |
|
|
JWN
144
DELISTED
Nordstrom
JWN
| $349M | 0.15% |
+5,825,099
| New | +$338M |
|
|
CIT
145
DELISTED
CIT Group Inc.
CIT
| $347M | 0.15% |
+7,431,500
| New | +$329M |
|
|
RAX
146
DELISTED
Rackspace Hosting Inc
RAX
| $336M | 0.14% |
+8,857,979
| New | +$372M |
|
|
IOC
147
DELISTED
Interoil Corporation
IOC
| $334M | 0.14% |
+4,811,515
| New | +$375M |
|
148
ResMed
RMD
$32.8B
| $330M | 0.14% |
+7,307,551
| New | +$347M |
|
149
Starwood Property Trust
STWD
$6.09B
| $327M | 0.14% |
+16,394,204
| New | +$350M |
|
150
State Street
STT
$52.2B
| $325M | 0.14% |
+4,979,105
| New | +$310M |
|
Similar funds
Capital Research Global Investors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital Research Global Investors, which disclosed 433 positions worth $235B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Philip Morris: 102,547,012 shares worth $8.88B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q2 2013 buy was Philip Morris: 102,547,012 shares worth $8.88B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $235B portfolio in Q2 2013.
- Capital Research Global Investors disclosed 433 positions in Q2 2013, its first 13F filing on record.
Based on Capital Research Global Investors's 13F filing for Q2 2013, filed 14 Aug 2013.